Evaluation of fidaxomicin use in patients with a macrolide allergy/intolerance
Journal of Antimicrobial Chemotherapy · 2023
DOI: 10.1093/jac/dkad036 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Wesley D Kufel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Binghamton University School of Pharmacy and Pharmaceutical Sciences, PO Box 6000, Binghamton, NY 13902-6000, USA. Hauptthemen laut MEDLINE: Hypersensitivity, Clostridium Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Practice, Binghamton University School of Pharmacy and Pharmaceutical Sciences, PO Box 6000, Binghamton, NY 13902-6000, USA.
- Department of Medicine Division of Infectious Diseases, State University of New York Upstate Medical University, Syracuse, NY, USA.
- Department of Pharmacy, State University of New York Upstate University Hospital, 750 East Adams Street, Syracuse, NY 13210, USA.
ORCID-Profile: Wesley D Kufel
Zitieren
APA
Kufel, W. D., Hitchcock, A. M., Delbalso, A. N., & Paolino, K. M. (2023). Evaluation of fidaxomicin use in patients with a macrolide allergy/intolerance. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad036
Vancouver
Kufel WD, Hitchcock AM, Delbalso AN, Paolino KM. Evaluation of fidaxomicin use in patients with a macrolide allergy/intolerance. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad036
BibTeX
@article{Kufel2023,
author = {Kufel, Wesley D and Hitchcock, Allison M and Delbalso, Alexis N and Paolino, Kristopher M},
title = {Evaluation of fidaxomicin use in patients with a macrolide allergy/intolerance},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2023},
doi = {10.1093/jac/dkad036}
}
EUVIMED